Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
$0.00
$0.02
$5K0.9617,522 shs2,020 shs
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$12.04
-5.6%
$14.18
$0.65
$34.77
$72.51MN/A2.18 million shs344,730 shs
KURI
Alkuri Global Acquisition
$9.20
$9.71
$9.02
$10.10
$396.80MN/AN/A147,671 shs
UPHL
UpHealth
$0.00
$0.00
$0.00
$0.49
$4K0.866,880 shs376 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%-50.00%-99.20%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
-5.57%-13.04%-24.18%+588.00%+435.11%
KURI
Alkuri Global Acquisition
0.00%0.00%0.00%0.00%0.00%
UPHL
UpHealth
0.00%0.00%0.00%0.00%-99.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/AN/AN/AN/AN/AN/AN/AN/A
KURI
Alkuri Global Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
0.00
N/AN/AN/A
KURI
Alkuri Global Acquisition
0.00
N/AN/AN/A
UPHL
UpHealth
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$2.47M29.35N/AN/AN/A
KURI
Alkuri Global Acquisition
$322.92M1.23N/AN/A$3.83 per share2.40
UPHL
UpHealth
$130M0.00N/AN/A$3.10 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76MN/A0.00N/AN/AN/AN/A7/21/2025 (Estimated)
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.77N/AN/AN/AN/AN/AN/A
KURI
Alkuri Global Acquisition
-$374.51MN/A0.00N/AN/AN/AN/AN/AN/A
UPHL
UpHealth
-$56.42M-$1.35N/AN/AN/AN/AN/AN/A

Latest KURI, KDLY, BTTX, and UPHL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.17N/A-$0.17N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/AN/AN/AN/AN/A
KURI
Alkuri Global Acquisition
N/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
5.43
5.42
KURI
Alkuri Global Acquisition
1.02
2.37
2.37
UPHL
UpHealth
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
KURI
Alkuri Global Acquisition
62.45%
UPHL
UpHealth
56.10%

Insider Ownership

CompanyInsider Ownership
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
50.50%
KURI
Alkuri Global Acquisition
N/A
UPHL
UpHealth
34.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4049.86 million24.23 millionOptionable
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A6.02 million2.96 millionN/A
KURI
Alkuri Global Acquisition
243.13 millionN/ANot Optionable
UPHL
UpHealth
1,75018.93 million12.45 millionNo Data

Recent News About These Companies

Lemon Dump Cake Recipe
DJUSIV Dow Jones US Business Support Services Index
UpHealth Inc Ordinary Shares UPHL
UpHealth, Inc. (UPHL)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)
As of 07/8/2025 01:59 PM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Kindly MD stock logo

Kindly MD NASDAQ:KDLY

$12.04 -0.71 (-5.57%)
As of 07/7/2025

Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.

Alkuri Global Acquisition NASDAQ:KURI

Alkuri Global Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was formerly known as Ark Global Acquisition Corp. and changed its name to Alkuri Global Acquisition Corp. in March 2020. Alkuri Global Acquisition Corp. was incorporated in 2020 and is based in Nashville, Tennessee.

UpHealth NYSE:UPHL

$0.0002 0.00 (0.00%)
As of 07/8/2025 01:36 PM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.